Menu

Equities

Sprayking Ltd Announces Stock Split, Rs 50 Cr Rights
Business, Equities, Market News, Markets, Result Updates - August 13, 2022

Sail reported a net profit of Rs. 804Cr.

SAIL reported a net profit of Rs. 804 crore.

SAIL on Wednesday posted a 79% fall in its consolidated net profit to Rs 804.50 crore during the June quarter, dragged by higher expenses. It had clocked Rs 3,897.36 crore in the June period of the 2021-22 fiscal, Steel Authority of India Limited (SAIL) said in a regulatory filing. The company’s total income rose to Rs 24,199.51 crore from Rs 20,754.75 crore in the year-ago quarter. The expenses increased to Rs 23,295.23 crore as against Rs 15,604.07 crore in June 2021.

EBITDA fell to Rs 2,606 crore compared to Rs 6,674 crore in June 2021. The revenue was at Rs 24,029 crore, up 16% year-on-year. The sales volume declined marginally to 3.15 million tonnes (MT) during Q1 of the current fiscal compared to 3.33 MT in June 2021.

Other parameters for the business:
The crude steel output was at 4.33 million tonnes, up from 3.77 MT in the same quarter of the preceding financial year. The sales were down to 3.15 MT as compared to 3.33 MT last year. The first quarter of FY23 saw challenges of higher input costs and serious market demand, both global and domestic, impacting the performance of the company. The high cost of production due to an increase in imported coking coal prices had an impact on the company’s bottom line. The decline in global demand and prices for steel had a direct bearing on the domestic market and price realization.

The first quarter of FY2 had higher input costs and subdued market demand, both global and domestic, impacting the performance of the company. The high cost of production due to high import prices of coking coal had an impact on the bottom line. The decline in global demand and prices for steel had a direct effect on the domestic market and price realisation. SAIL has infrastructure projects to gain momentum, which will boost the demand for their products. They are confident of improved performances in the second half of the current financial year with a significant reduction in the price of imported coal and an uptick in demand.

Valuations:
The EPS for SAIL is Rs. 22.2. The ROE and ROCE were at 25.1% and 24.3%, respectively. The EBITDA ratio is 2.52. While the P/B ratio is 0.62, The P/E ratio is at 3.58 times, whereas the 5 year P/E is at 4.49 times. The scrip closed at Rs.81.6, down by 3.49%.

, , , , , 0 Comment
Read More
Bharat Forge Ltd Q1 FY23 Result Updates.
Business, Equities, Market News, Markets, Research, Result Updates - August 13, 2022

Bharat Forge Ltd Q1 FY23 Result Updates. Standalone revenue and EBITDA witnessed steady growth on a sequential basis.

Bharat Forge Ltd Q1 FY23 Result Updates.
Standalone revenue and EBITDA witnessed steady growth on a sequential basis.

Bharat Forge reported a consolidated net profit of Rs 160.37 crores as compared to Rs.152.74 crores in June 2021 and Rs. 231.85 crores in the March quarter.
Revenue from operations stood at Rs. 2851.46 crores from Rs. 2107.68 crores.
The total expenses during the June quarter were Rs. 2643.95 crores as compared to Rs. 1874.24 in June 21.
At a consolidated level, the European operations have delivered a stable performance as per plan, inspite of high input prices and weak market conditions.

According to Bharat Forge the consolidated results are not comparable with those of the last fiscal due to its alignment of accounting periods of all the subsidiaries, associates and joint ventures for a better presentation of the operating performance of the group.

The company’s standalone performance in Q1 FY23 was steady with revenue and EBITDA witnessing growth on a sequential basis. Topline grew by 5.1% to Rs 17,594 million while EBITDA grew by 6.8% to Rs 4,600 million. Export revenues at Rs 10,475 million and PV export revenues at Rs 1,942 million are at an all time high.
Standalone revenues at Rs 17,594 million in Q1FY23 grew by 5.10% as compared to Q4 FY22 on back of 11.5% growth in Export revenues. Domestic revenues declined by 3.7% due to decline in MHCV production during the quarter. EBITDA margins at 26.1% in the current quarter is a marginal improvement of 40 bps as compared to Q4 FY22 despite a sharp increase in energy cost. PBT before Exchange gain/ (loss) of Rs 3,532 million in Q1 FY23 as against Rs 3,520 million in Q4 FY22.

India automotive business witnessed a sequential decline in revenue in line with the underlying market drop.

MHCV & PV production during the quarter declined by 10% & 4% respectively. In line with the underlying market decline, BFL’s revenues into these segments also witnessed sequential decline. India automotive business witnessed a sequential decline in revenue in line with the underlying market drop as production of medium and heavy commercial vehicles and passenger vehicles in the industry fell.
However, automotive export revenue grew, driven by both commercial and passenger vehicle segments, adding in Europe, the geo-political crisis impacted overall demand and supply chain. The Indian operations secured new business worth around Rs 350 crore across automotive and industrial applications during the period.
The India industrial business continues to display stable performance with the segment registering growth on a YoY basis while witnessing a marginal dip compared to the previous quarter.

The international automotive export revenues has witnessed growth on both QoQ & YoY basis across Commercial & Passenger Vehicle segments. Revenues from the CV segment has grown by 13.5% sequentially while the PV segment revenues have grown by 13.8% sequentially. PV revenues at Rs 1,942 million. Heavy Truck registration is marginally up while the Passenger Vehicle segment is down 14%. The geo-political crisis has had an impact on overall demand and on the supply chain.
The international industrial segment has witnessed growth on both Sequential and YoY basis driven by growth in key sectors.
The new greenfield aluminium forging facility in North America is still in a ramp-up phase and operating at low utilisation levels, which has adversely impacted the overall quarterly profitability.

The shares of Bharat Forge Ltd are trading at Rs. 790.60, up by 7.43%.

Valuations:

The return on equity (ROE) is 15.4% for the quarter ended June 2022. The price-to-earning (P/E) ratio stood at 38.3. The return on capital employed (ROCE) for the company is 11.5%. The price to book value Bharat Forge Ltd is 5.60. The EV/EBITDA is 19.6. EPS for the quarter is Rs. 23.5.

Lumax recorded its biggest ever profit.

 

Ajmera Realty reported total revenue of Rs. 55 Cr. in Q1 FY23.

 

J B Chemicals and Pharmaceuticals Limited  Q1 FY23 Result Updates. Higher treasury income and other costs hamper net profit.

 

 

Indigo Paints revenue up from Rs.156 Cr to Rs.223.99Cr.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

, 0 Comment
Read More
Syngene International Ltd Q1FY24 results updates
Business, Equities, Market News, Markets, Research, Result Updates - August 12, 2022

Max Healthcare Institute Ltd Q1 FY23 Result Updates. Robust growth in revenue & EBITDA driven by normalization of patient footfalls.

Max Healthcare Institute Ltd Q1 FY23 Result Updates.
Robust growth in revenue & EBITDA driven by normalization of patient footfalls.

Max Healthcare reported a net profit of Rs. 229 crores, up by 12% YoY from Rs. 205 crores driven by annual price revision and normalisation of patient footfalls. Sequentially the net profit increased from Rs. 172 crores in the previous quarter.

Gross revenue stood at Rs. 1,473 Cr, a growth of 6% YoY and 14% QoQ .Net revenue increased to Rs. 1393 crores from Rs. 1322 crores in June 21, up by 5% YoY.Q1 FY23 performance reflects normalisation of revenues and operating EBITDA post Omicron wave in the previous quarter.
Max Healthcare stated that EBITDA stood at ₹370 crore compared to ₹360 crore in the corresponding quarter last year (Q1 FY22) and ₹304 crore in the previous quarter (Q4 FY22) growth of 3% YoY and 22% QoQ.

Improvement in all operational and financial parameters.

The Operating EBITDA margin stood at 26.6% for the quarter, compared to 25.3% in Q1 FY22 and 24.9% in Q4 FY22.
EBITDA per bed improved to Rs. 62.0 lakhs in Q1 FY23, from Rs. 45.4 lakhs in Q1 FY22 and Rs. 56.4 lakhs in Q4 FY22.
Bed occupancy in Q1 FY23 stood at 74%; 1% of total occupied beds were used for Covid‐19 patients compared to 7% in Q4 FY22 and 39% in Q1 FY 22.
Cash from Operations stood at Rs. 237 Cr in Q1 FY23.
Net Debt including Put Option liability of Rs. 141 Cr as on June 30, 2022 was Rs 217 Cr
Occupied Bed Days (‘OBD’) during the quarter increased by 9% over the previous quarter
Average revenue per occupied bed (ARPOB) for Q1 FY23 stood at Rs. 66.0k versus Rs. 51.5k in Q1 FY22 (+28% YoY) and Rs. 63.5k in Q4 FY22 (+4% QoQ)
Increase in ARPOB was led by improvement in payor mix and surgical mix, normalisation of OPD footfalls and annual price revision.
Digital revenue from online marketing activities and web-based appointments stood at INR 232 Cr, i.e. 16% of overall revenue.
Max Lab (Non-captive pathology vertical) reported gross revenue of Rs. 26 Cr.
Max@Home gross revenue during the quarter was INR 32 Cr, a growth of 10% over Q4 FY22 & 18% over Q1 FY22.
The growth in Q1 FY23 revenue and Operating EBITDA was driven mainly by improvement in payor mix, annual price revision and normalisation of patient footfalls after the Omicron wave waned in mid of Feb’22.

The shares of Max Healthcare are trading at Rs. 361, down by 2.94%.

Valuations:

The return on equity (ROE) is 10.3% for the quarter ended June 2022. The price-to-earning (P/E) ratio stood at 54.8. The return on capital employed (ROCE) for the company is 12.2%. The price to book value Max Healthcare is 5.54. The EV/EBITDA is 32.3. EPS for the quarter is Rs. 6.51.

Lumax recorded its biggest ever profit.

 

Ajmera Realty reported total revenue of Rs. 55 Cr. in Q1 FY23.

 

J B Chemicals and Pharmaceuticals Limited  Q1 FY23 Result Updates. Higher treasury income and other costs hamper net profit.

 

 

Indigo Paints revenue up from Rs.156 Cr to Rs.223.99Cr.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

, 0 Comment
Read More
Everest Kanto reported a total revenue of Rs. 380 Cr.
Business, Equities, Markets, Result Updates - August 12, 2022

Cummins India's PAT falls in Q1 FY23.

Cummins India’s PAT falls in Q1 FY23.

Cummins India on Wednesday reported a 20% decline in PAT at Rs 198.13 crore  for June quarter. The company’s consolidated profit after tax (PAT) was Rs 246.94 crore in the year-ago period. The consolidated sales during this period increased 41.47% to Rs 1,666.11 crore from Rs 1,177.71 crore in the June quarter of 2021. Domestic sales were 1,172 Cr., a 36% increase over June 2021 and a 12% increase over March 2022.

The export sales were valued at  485 Cr., increased by 58% compared to June 2021 and by 14% compared to March 2022. The profit before tax at 264 Cr. is lower by 13% compared to June 2021 and higher by 8% compared to the March 2022 quarter.

Cummins India is planning to increase its sales volume.

They are closely monitoring the results of the geopolitical events unfolding in different parts of the world and their impact on global demand and the supply chain. Cummins India effectively deals with challenges and monitors any potential impact of rising interest rates on demand. However, they remain optimistic about the short-to-medium-term demand outlook. The company believes that the strong demand from various end-markets may likely be sustained, but at the same time, high inflation and supply chain issues will, in all probability, continue to impact the industry.

The company believes that the strong demand from various end markets may likely continue. At the same time, surging inflation and supply chain disruptions will, in all probability, continue to impact the industry. The company, being part of the global supply chain, is well placed to manage parts supplies to mitigate the impact on revenue and profitability. They are closely monitoring the results of the geopolitical events unfolding in different parts of the world and their impact on global demand and the supply chain. Considering the uncertainty, the company will not provide any guidance for FY 23.

Valuations:

The P/E for the company is at 40.0 times and the 5Y P/E ratio is 28.6 times. The ROCE is 21.3%.While the company’s ROE is 16.9%.The EVEBITDA ratio is 26.0.EPS for the company is Rs. 30.6 per share. The debt-to-equity ratio is currently 0.08.The scrip closed at Rs.1239 and was up by 6.15% on Thursday.

, , , , 0 Comment
Read More
Porter Extends Series F: New $110 Million Boost Powers Indian Logistics
Business, Equities, Markets, Result Updates - August 12, 2022

VRL Logistics has reported its highest revenue since the pandemic.

VRL Logistics has reported its highest revenue since the pandemic.

VRL Logistics reported a total revenue of Rs. 717 Cr. in the June quarter as against Rs. 665 Cr. in the March quarter. The company reported a net profit of Rs. 49 Cr. in Q1 FY23 compared to Rs. 56 Cr. in Q4 FY22 and Rs. 6 Cr. in Q1 FY22. 117 Cr. in the June quarter compared to Rs. 126 Cr. in the March quarter. The growth in the transport business is contributing 90% of the total revenue and was at 609 Cr. The increase was due to tonnage of around 44% and the other was due to realization.

New branch additions:

The company added 68 branches in Q1 FY23, giving an overall of 157 total branches. It intends to map out new locations and expand its reach. The new branches contributed 8% in Q1 FY23. They are in touch with the small operators as this can help them to have a strong base. The government has made it a norm in April to generate an E-invoice above 20 Cr, which will be decreased to 10 Cr. in the near future. This indicates that the business will be done in a more organized way.

Many commodities and new contracts are gradually shifting to the company as a result of their proper compliance procedure, and the number of customers has increased from 4 lakh in pre-covid level to 7 lakh customers. The diesel cost has increased from 29% of the total revenue to 31%. This rise is due to an increase in procurement costs, which was at Rs. 85 to Rs. 93 in the current quarter. The company is unable to get fuel from the refinery, which was 40% of their consumption. It declined to 25% in Q4 FY22 and null in the current quarter due to increases in bulk purchases by the government due to which they lost Rs.2 per liter.

The employee costs is constant in VRL Logistics. EBIT was 69 cr in Q1. The company has also increased the useful life of the asset from 9 to 15 years. The net free cash was at 100 Cr, out of which 85 Cr was used to fund Capex for the goods transport business.

Valuations:

The P/E for the company is at 24.8 times, and the 5 year P/E and 3 year P/E ratios are 27.8 times and 27.3 times, respectively. ROCE for VRL Logistics is at 22.7%. While the company’s ROE is 25.1%.The EVEBITDA ratio is 11.8.EPS for the company is Rs. 24.4 per share. The debt to equity ratio is at 0.82. The scrip closed at Rs. 604.45 and was up by 0.92% on Thursday.

, , , 0 Comment
Read More
Safex Chemicals Plans ₹450 Cr IPO to Strengthen Financial Health and Growth
Business, Equities, Market News, Markets, Research, Result Updates - August 11, 2022

Tata Chemicals Ltd Q1 FY23 Result Updates. Strong revenue, and EBITDA growth amidst a favourable market environment and a challenging cost situation.

Tata Chemicals Ltd Q1 FY23 Result Updates.
Strong revenue, and EBITDA growth amidst a favourable market environment and a challenging cost situation.

Tata Chemicals Ltd reported a net profit of Rs. 637 crores, soared by 86% from Rs. 342 crores in Q1 FY22. The net profit increased from Rs. 470 crores in the March quarter. The PAT margin stood at 16%.
Revenue from operations of the company jumped by 34.15% during the June quarter at Rs 3,995 crore compared to Rs 2,978 crore in June 2021. Sequentially the revenue increased from Rs. 3,418 crores in the previous quarter.
Earnings before interest, tax, depreciation, and amortization stood at Rs. 1015 crores as compared to June 21 at Rs. 601 crores, up by 69% YoY. The EBITDA margin is at 25%.
The profit before tax is Rs. 797 crores, increased by 86% YoY from Rs. 428 crores.
Input costs mainly energy continue to remain at elevated levels.

Robust soda ash demand continues across all geographies and applications.

India’s business saw higher soda ash and bicarb realizations aided by strong market demand and market tightness. EBITDA rose due to improved realizations, which offset a significant increase in raw material and energy costs during the quarter. Revenue grew by 48% YoY and EBITDA grew by 67%.

Overall US volumes remain strong with growth in domestic and export markets and the overall market remained tight. Export prices remain strong & at above pre-covid levels. Maintenance shutdown in one dryer leading to 10K MT production loss. Gas prices remain at elevated levels. The revenue increased by 34%.

In the UK business EBITDA improved on account of improved realizations which offset a significant increase in raw material and energy costs. The volumes were marginally lower in Q1 FY 23 and revenue improved by 31% YoY.

Kenya’s operation maintained its steady performance with higher sales volume and higher export realizations. Margins improved against the previous year on account of higher realizations and robust market demand. The unit continues its focus on optimizing cost and improving efficiencies.

Rallis recorded higher revenues driven by robust growth in crop care. Margins are impacted due to cost inflation and competitive pricing. Crop care margins improved while seeds margin was impacted and continue to be under pressure.

In June, Tata Chemicals Europe officially opened the UK’s first industrial-scale carbon capture and usage plant, a move the Tata Group company said signals a key milestone in the race to meet the country’s net-zero targets. The 20 million pound investment was completed by Northwich-based Tata Chemicals Europe (TCE) in northwest England, one of Europe’s leading producers of sodium carbonate, salt, and sodium bicarbonate.

The shares of Tata Chemicals Ltd are trading at Rs. 1077.80, up by 0.34%.

Valuations:

The return on equity (ROE) is 7.58% for June 2022. The price-to-earning (P/E) ratio stood at 17.5. The return on capital employed (ROCE) for the company is 8.40%. The price to book value of Tata Chemicals Ltd is 1.53. The EV/EBITDA is 10.5. EPS for the quarter is Rs. 61.2.

Lumax recorded its biggest ever profit.

 

Ajmera Realty reported total revenue of Rs. 55 Cr. in Q1 FY23.

 

J B Chemicals and Pharmaceuticals Limited  Q1 FY23 Result Updates. Higher treasury income and other costs hamper net profit.

 

 

Indigo Paints revenue up from Rs.156 Cr to Rs.223.99Cr.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

, 0 Comment
Read More
Jindal Steel & Power Q1 FY26: Profits Surge on Operational Gains and Strategic Growth
Business, Equities, Market News, Markets, Research, Result Updates - August 11, 2022

Hindalco Industries Limited Q1 FY23 Result Updates. Stronger Q1 backed by operational efficiencies.

Hindalco Industries Limited Q1 FY23 Result Updates.
Stronger Q1 backed by operational efficiencies.

Hindalco Industries Limited reported a net profit of Rs. 4,119 crores, up by 48% YoY as compared to Rs. 2,787 crores in June 2021, driven by strong US sales and higher revenue that cushioned the impact of pricier raw materials. On a sequential basis, the profit has increased 7% QoQ from Rs 3,851 crores during the March quarter.
Revenue for the quarter increased to Rs. 58,018 crores, up by 40.28% YoY from Rs. 41,358 crores in the same quarter last year. On a sequential basis, the revenue scaled 4% from Rs 55,764 crore recorded in the previous quarter.
Earnings before interest, tax, depreciation, and amortization stood at Rs. 8640 crores as against RS. 6790 crores in Q1 FY22, increased by 27% YoY.

Excellent results driven by robust performance by Novelis, Aluminium Downstream, and Copper businesses, supported by operational efficiencies and higher volumes.

Novelis reported its best-ever quarterly EBITDA and EBITDA per tonne primarily due to higher product pricing, favourable product mix, and recycling benefits.
Novelis’ profit for the quarter stood at $307 million, up 1% YoY.
Revenue was at $5.1 billion against $3.9 billion YoY, up 32%, driven by higher global aluminium prices. Total shipments of flat rolled products (FRPs) were at 962 Kt against 973 Kt in the year-ago quarter, marginally lower due to supply chain constraints.

Aluminium upstream revenues stood at Rs 8,699 crore. Ebitda stood at Rs 3,272 crore, up 41% YoY, primarily due to favourable macros, higher volumes, and better operational efficiencies, partially offset by higher input costs. Upstream Ebitda margins were at 38%.
Aluminium downstream logged revenues of Rs 2,740 crore.
Ebitda stood at Rs 158 crore, up 305% YoY, primarily due to better pricing of downstream products. Ebitda per ton for Aluminium downstream stood at $261 against $64 YoY, up 306% YoY.

The copper business witnessed an improvement of 48% YoY to Rs 10,529 crores due to higher volumes and a rise in global prices. EBITDA at Rs.565 crore, up 116% YoY, on the back of higher volumes, better operational efficiencies, and improved by-product realizations.
The shares of Hindalco Industries Limited are trading at Rs. 438.05, down by 0.50%.

Valuations:

The return on equity (ROE) is 18.5% for June 2022. The price-to-earning (P/E) ratio stood at 6.54. The return on capital employed (ROCE) for the company is 16.2%. The price to book value of Hindalco Industries Limited is 1.24. The EV/EBITDA is 4.59. EPS for the quarter is Rs. 67.

 

 

Lumax recorded its biggest ever profit.

 

Ajmera Realty reported total revenue of Rs. 55 Cr. in Q1 FY23.

 

J B Chemicals and Pharmaceuticals Limited  Q1 FY23 Result Updates. Higher treasury income and other costs hamper net profit.

 

 

Indigo Paints revenue up from Rs.156 Cr to Rs.223.99Cr.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

, 0 Comment
Read More
BEL to manufacture hydrogen fuel cells with technology from TEV.
Business, Equities, Markets, Result Updates - August 11, 2022

Lumax recorded its biggest ever profit.

Lumax recorded its biggest ever profit.

Lumax Technologies reported a 539.59% jump in its profit to Rs.21.81 crore as against Rs. 3.14 crore in June 2021 and 20 crore in March 2022. The total sales were at Rs. 421.93 Cr compared to Rs. 260 Cr in June 2021 and Rs. 417 Cr in March 2022. EBITDA margins stood at 11.5%, up by 430bps from Q1 FY22. The company expects a bounce back in domestic exports as the world economy is witnessing a strong recovery.

A long way to go ahead:

The auto industry was under pressure in the last quarter due to a shortage of semi-conductors, rising commodity prices on account of inflation, and supply chain disruptions. However, the volumes have increased this year as the economy is stabilising. The company has witnessed consistent improvement in all the sectors, which indicates that the mobility industry is revisable and in its growth stage. The growth catalysts will be  OEM offtake, an improving demand scenario, strong aftermarket demand, and increased wallet share with its major customers. The key highlights for Q1 FY23 are normal economic activity, healthy retail sales, demand in the PV segment amid new launches in the SUV domain, a reduction in excise duty, and a reduction in key raw material prices towards the end of the quarter April-May 2022.

The increasing demand for safety and comfort requirements in automobiles is paving the way for companies focused on supplying import-substitute products. With the high growth forecast in the vehicle industry, the auto component sector is anticipated to rise twice in FY 2022–23. The government’s recent announcements of PLI schemes regarding ACC Batteries and Auto & Auto Components are expected to pave the way ahead for the creation of an automotive value chain.

Valuations:

The ROCE and ROE is at 18.4% and 13.0% respectively for Lumax Technologies. P/E ratio is at 17 times, whereas 5 years and 3 years P/E ratio is at 16.5times and 14.4times. EVEBITDA is 7.97 times. The EPS is at Rs. 12.9 and P/B ratio is at 2.79 times. The stock closed at Rs.222 down by 3.39% on Wednesday.

, , , , 0 Comment
Read More
AstraZeneca Pharma India Q1 2026: Strong Growth and Resilience
Business, Equities, Market News, Markets, Research, Result Updates - August 9, 2022

J B Chemicals and Pharmaceuticals Limited  Q1 FY23 Result Updates. Higher treasury income and other costs hamper net profit.

J B Chemicals and Pharmaceuticals Limited  Q1 FY23 Result Updates.

Higher treasury income and other costs hamper net profit.

 

 

JB Pharma reported a net profit of Rs. 105 crores, fell by 12% YoY from Rs. 119 crores on account of higher treasury income in Q1 FY22, non-cash ESOP cost, depreciation on account of acquired brands, and finance costs in Q1 FY23

The revenue stood at Rs. 784 crores for the June quarter, up by 30% YoY from Rs. 606 crores in June 2021.

The earnings before interest, tax, depreciation, and amortization stood at Rs. 173 crores as compared to Rs. 164 crores, up by 6% YoY.

The profit before tax stood at Rs. 142 crores from Rs. 158 crores, slipped by 10% YoY.

Operating EBITDA  grew by 16% to Rs. 190 crores. Gross margins were at 62.7% v/s 64.2%. Excluding Azmarda, gross margins for the business were relatively flat YoY. Overall material cost continues to remain challenging whilst softening was seen in certain packing material. Excluding non-cash ESOP cost, employee cost increased by 19% due to increments and manpower costs for acquired brands. Non-cash ESOP cost as a percentage of reported EBITDA was at 10%as compared to 20% of reported EBITDA in Q4 FY22.

Other expenses increased on account of normalization of marketing expenses as compared to Q1 FY22 and a significant increase in fuel costs, freight expenses, and logistics costs for the exports business on a YOY basis, whilst sequentially some softening was seen in international freight.

Depreciation increased by 44% to INR 26 crores on account of the amortization of the acquired brands.

 

Robust revenue growth despite a challenging operating environment.

 

JB recorded robust revenue growth at 30% despite a challenging operating environment. Organic revenue growth was around 20%.  The domestic Formulation business continued its strong performance growing at 34% to INR 418 cr. Organic revenue growth was around mid-teens. International business revenue grew by 28% to Rs. 366 crores. All the three businesses viz. Exports formulations, CMO, and API business performed well in the quarter.

 

During the quarter, the international business recorded robust revenue growth of 28% to Rs. 366 crores. Exports formulations, CMO, and API business recorded growth of 11%, 108%, and 17% respectively. South Africa unit registered growth in both public & private markets; robust tender demand; new launches in the private market. Russia local sales remained steady; Receivables looked positive from the region.  CMO revenue crossed Rs. 100 crores for the first time in a quarter due to a strong surge in account demand for lozenges and liquids from key partners. The order book continues to remain robust.

 

Domestic business records highest ever sales in a quarter of Rs.  418 crores registering growth of 34%. Organic revenue from the domestic business grew around the mid-teens out-pacing industry growth rate. JB continues to remain the fastest growing company among the top 25as per IQVIA MAT June 22 data. As per MAT June 22 data, JB ranks 23rd as compared to 25thin Q4 FY22. The acquired brands from Sanzyme performed well with Sporlac gaining market share during the quarter.

 

The shares of J B Chemicals and Pharmaceuticals Limited closed at Rs. 1861.40, up by 0.46%.

 

Valuations:

 

The return on equity (ROE) is 18.1% for June 2022. The price-to-earning (P/E) ratio stood at 38.7. The return on capital employed (ROCE) for the company is 28.4%. The price to book value of J B Chemicals and Pharmaceuticals Limited is 6.72. The EV/EBITDA is 24.8. EPS for the quarter is Rs. 48.1.

 

 

 

 

 

 

 

 

 

 

 

Cipla Q1 results: Lower Covid-19 drug sales to hamper revenue growth

 

Ashok Leyland Q1 FY23 Result Update. Volume growth to improve net profit; revenue doubles.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Infosys reports a net profit of Rs.5,350Cr. in Q1 FY23. 

 

L&T Technology Services Ltd Q1 Results Update.

 

HUL Q1 FY23 Result Update: HUL beats estimates with Rs 2,381-cr net profit in Q1; revenue up 19.6%

 

 

 

 

 

, 0 Comment
Read More
24% Tariffs: Japan Faces Economic Shockwaves
Business, Equities, Market News, Markets, Research, Result Updates - August 8, 2022

Titan Company Limited Q1 FY23 Result Updates. 13-fold jump in year-on-year net profit at Rs 793 crores.

Titan Company Limited Q1 FY23 Result Updates.

13-fold jump in year-on-year net profit at Rs 793 crores.

 

 

Titan reported a net profit of Rs. 793 crores, up by from Rs. 61 crores in Q1 FY23.
Total income for the June quarter jumped by 199% a YoY to Rs 8,649 crore compared with Rs 2,890 in Q1 FY22, driven by strong festive demand in a near normal Q1 that came after a gap of two Covid disrupted periods.

Advertising and campaign expenses stood at Rs. 171 crores, increased by 373% YoY as the company ramped up investing in brands across businesses. Standalone EBIT at Rs. 1,121 crores soared by 478% YoY from Rs. 209 crores with margins at 13.0% was the best for the Q1 period and second best overall in the last 3 years.

Profit before tax stood at Rs. 1066 crores from Rs. 82 crores in Q1 FY22.

All the key Divisions recorded healthy margins aided by better realizations across product categories.

 

Titan’s jewellry business registered an income (excluding bullion sales) of Rs 7,600 crore compared with Rs 2,467 crore in the year-ago quarter, up 208 % YoY led by a good Akshaya Tritiya sales and a better-studded mix compared to June 2021. Sales growth was driven by both buyer and ticket sizes, with new buyer contribution continuing to be quite robust at 46%. Whilst the wedding segment recorded a healthy growth of 178% YoY, its contribution to the overall sales was marginally lower. The studded sales ratio at 26% is moderately better than pre-pandemic levels for the first quarter, indicating a full recovery. Jewellry business reported an EBIT of Rs 1,027 crore against Rs 207 crore in the same quarter of the previous year.

The watches and wearables business reported its best quarterly income of Rs 785 crore, up 169% against  Rs 292 crore YoY. The watches and wearables business reported an of EBIT of Rs 103 crore against a loss of, Rs 56 crore YoY.

Eyecare business also reported its highest quarterly income of Rs 183 crore, up 173% over Rs 67 crore YoY. Eyecare business reported an EBIT of Rs 36 crore against a loss of Rs 13 crore YoY.

Other businesses comprising Indian dress wear and fragrances & fashion accessories reported a 300% YoY rise in income at Rs 56 crore compared with Rs 14 crore YoY. Other businesses reported a loss of Rs 10 crore against a loss of Rs 16 crore YoY.

The company said it added a net of 125 stores during the year. The company’s retail chain (including Caratlane) has 2,303 stores across 366 towns with an area exceeding 2.9 million square feet, as of June 2022.

The shares of Titan Company Limited are trading at Rs. 2440, up by 034%.

 

Valuations:

 

The return on equity (ROE) is 26.4% for June 2022. The price-to-earning (P/E) ratio stood at 73.1. The return on capital employed (ROCE) for the company is 21.4%. The price to book value of Titan Company Limited is 23.4. The EV/EBITDA is 48.2. EPS for the quarter is Rs. 3.31.

 

 

 

 

 

 

 

 

 

 

 

Cipla Q1 results: Lower Covid-19 drug sales to hamper revenue growth

 

Ashok Leyland Q1 FY23 Result Update. Volume growth to improve net profit; revenue doubles.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Infosys reports a net profit of Rs.5,350Cr. in Q1 FY23. 

 

L&T Technology Services Ltd Q1 Results Update.

 

HUL Q1 FY23 Result Update: HUL beats estimates with Rs 2,381-cr net profit in Q1; revenue up 19.6%

 

 

 

 

 

, 0 Comment
Read More